Breaking News

Animal Experiments: Illogical, Unscientific and Pointless

Getting your Trinity Audio player ready...
Print Friendly, PDF & Email

Pharmaceutical companies conduct initial trials on animals to determine the safety of new drugs. If a drug does not harm an animal, it is deemed safe for human consumption. However, if an experiment shows that a drug causes harm to an animal, the results are dismissed due to anatomical and physiological differences between animals and humans.

This is how pharmaceutical companies use animal experiments to deceive the public about the safety and effectiveness of drugs. 

The evidence overwhelmingly suggests that animal experiments are unscientific, unreliable, and unethical.  But the practice continues.  Why?

The primary reason for perpetuating animal experiments is financial.


Let’s not lose touch…Your Government and Big Tech are actively trying to censor the information reported by The Exposé to serve their own needs. Subscribe now to make sure you receive the latest uncensored news in your inbox…


By Dr. Vernon Coleman

One of the key techniques used by pharmaceutical companies in order to get new products onto the market is to perform initial trials on animals other than human beings. Animal experiments offer drug companies an enormous advantage: if an experiment shows that a drug does not harm a particular animal then that experiment can be used to help the drug onto the market. The company will suggest that the absence of any serious problems when the drug was given to an animal shows that the drug will probably be safe when given to human patients.

But, on the other hand, if an experiment shows that a drug causes serious problems when given to an animal the results will be dismissed on the grounds that animal experiments cannot be regarded as relevant to human beings because of the enormous anatomical and physiological differences between, on the one hand, human beings and on the other hand cats, dogs, monkeys, rabbits, rats, mice and other creatures.

Many outside observers who do not fully comprehend the depths of dishonesty to which the drug industry will stoop find it difficult to believe that anyone could get away with such blatant double-edged trickery. But this is exactly how drug companies operate.

It is difficult to understand how any medical scientist can possibly defend the use of animal experiments as part of a drug testing programme. The usefulness and reliability of animal experiments have been so devalued in recent years that I do not believe that any reputable, independent scientist could possibly attempt to defend the use of animal experiments on logical, scientific grounds.

Those who perform and support animal experiments are so embarrassed and ashamed of what they do that they frequently use euphemisms to disguise their activities. It is quite common, for example, for experimenters to talk of animals “taking part” in experiments and “helping us with our research.” The word “experiment” has been replaced by the word “procedure,” which is less evocative. Experimenters have their own language. Here are just a few choice phrases they use (and their meanings):

  • vocal response = crying
  • major airway embarrassment = choking
  • reacting to adverse stimulation with vigorous motor responses = trying to escape
  • binocular deprivation = sewing the eyes up
  • decapitation = head removal
  • exhibiting lethal behaviour = dying
  • startle reflex = flinching
  • aversive electrical stimulation = electric shocks
  • thermal injury = burn or scald


In unguarded moments even the medical establishment acknowledges that animal experiments are absurdly unreliable. The British Medical Association is, as one would expect it to be, a staunch supporter of animal experimentation. But this stance becomes difficult to understand when one studies the British Medical Association’s book ‘The BMA Guide to Living With Risk’ (first published in 1987) in which readers are told that: “if salt and sugar were being tested as potential food additives today, and if judgement of acceptability was to be based purely on the laboratory and animal testing, it is unlikely that either would be permitted for use in food.”

It is difficult to imagine a simpler or more damning indictment of animal experimentation than to admit that animal experiments are so unreliable that neither salt nor sugar (just two of many other commonly consumed substances which are known to cause serious problems when given to other members of the animal kingdom) would pass safety tests if animal tests were relied upon!

The very unreliability and unpredictability of animal experiments make them valuable. Drug companies test on animals so that they can say that they have tested their drugs before marketing them. If the tests show that the drugs do not cause serious disorders when given to animals the companies say: ‘”There you are! We have tested our drug – and have proved it to be safe!” If, on the other hand, tests show that a drug does cause serious problems when given to animals the companies say: “The animal experiments are, of course, unreliable and cannot be used to predict what will happen when the drug is given to humans. We have, however, tested our drug.” This double-edged absurdity, which only works because of the enormous influence that the pharmaceutical industry holds over governments and regulatory authorities, and which would sound like a nightmare conjured up by a paranoid lunatic if it were not so easily proved, means that the industry never loses and patients never win.

In order to disguise the real (commercial) reasons for performing animal experiments drug companies will sometimes claim that they don’t like doing animal experiments but do them because they are required to do so by the law. This is not true. There are, for example, no laws in Britain requiring animal experiments to be performed during drug testing. Drug companies say that they are required to perform animal experiments by the law. Government spokesmen say that it is drug companies who choose to do animal experiments in order to test the safety of their drugs.

When the drug company Roussel, one of the biggest in Europe, was taken to court by the British Government because of advertisement claims for an anti-arthritis drug called Surgam, the company, which had claimed in advertisements published in the British Medical Journal that the drug was gentle on the stomach was asked to produce the evidence for this claim. The only evidence Roussel produced was from experimental studies on two animal tissues (neither of which were stomach tissue) which they had combined in order to support their claim. Even the expert witnesses called by Roussel in its defence testified that data from animals could not be extrapolated safely to patients.

You might imagine that after this fiasco drug companies would be wary about making claims (either for efficacy or safety) based on animal experiments. You would be wrong. Nothing has changed. And medical journals still allow drug companies to publish advertisements for drugs which have been tested on animals. I know of no medical journal editor who has refused to accept advertisements for products which have been tested on animals. (For the record The European Medical Journal, which I edit, carries no drug company advertising at all – and, indeed, accepts no paid advertising of any kind).

Scientists outside the pharmaceutical industry support this sham for several reasons.

First, of course, animal experiments have now been used for so long and by so many scientists that thousands of reputations would be irrevocably shattered if it were accepted by the research industry that the work they have been doing for so many years was fatally flawed.

Second, it is remarkably quick and simple to plan, research, write and publish scientific papers if you are using animals. Decent and useful research, involving human patients, is much harder to organise – and since most of the medical scientists using animals in experiments are not medically qualified most of them would not, in any case, be allowed to perform any sort of clinical research. Prolific publishing (usually accompanied by optimistic conclusions about the value of the research) is the best way to ensure a steady income from grants. It is the quantity, not the quality of research which governs the financial results. The charities which pay for much of the animal research done want to be able to fill their annual reports with impressive and optimistic accounts of research in progress.

The second-rate scientists who perform animal experiments outside the pharmaceutical industry are undoubtedly grateful to the industry for creating and maintaining the myths which support the milieu in which they work. And the industry in turn, recognising that the fact that universities still perform animal experiments supports the validity of THEIR work is also grateful: often commissioning highly paid research work from “independent” scientists in universities and colleges. In some universities, whole departments are financed exclusively by the drug industry.

The myth that animal experiments are of value to doctors and patients is sustained because the vast majority of doctors – the only people who could expose the absurd rigmarole for the sham that it is – are either uninterested in how drugs are tested (and apathetic about the dishonesty involved) or are so beholden to the industry that they are unwilling or unable to criticise it. The vast majority of the thousands of medical journals in existence rely to a greater or lesser extent on drug industry advertising to stay alive and so the editors of these journals are reluctant to publish anything critical of any aspect of the system as it operates.

Articles criticising the drug industry, the way drugs are tested or the use of animal experiments are rare. The existence of so many medical journals, largely sustained by drug company advertising, means that there is a steady and constant demand for new scientific papers. And so, the whole system is self-supporting. The industry needs to publish research papers in order to satisfy the regulatory authorities and to convince possibly sceptical doctors that their products have been well tested and proven to be both efficacious and safe. Independent researchers need to publish papers in order to provide the charities which fund their work with evidence with which to impress their subscribers and donors. And the journals need articles to publish.

Those who perform and defend animal experiments sometimes try to explain away the differences which exist between the results obtained when drugs are given to animals and when drugs are given to human beings by claiming that the dosages used when giving drugs to animals are too high. Strangely, they never bother to explain why they deliberately make the dosages they give so high as to be of no value. The truth is that no one does know how much of a drug to give to an animal in the hope of obtaining results which might be relevant to an animal (a human being) weighing a hundred or a thousand times as much and having entirely different physiological and anatomical systems.

The differences in results obtained when giving drugs to children and adults are so vast that paediatricians frequently complain when drug companies fail to perform special trials on children. Similarly, all good physicians know that adult human beings of different sizes and different ages may respond in different ways to the same drug. (There is something quite absurd about giving a 7-stone woman and a 20-stone man exactly the same dose of an antibiotic for example). Many drug companies now warn prescribers that special dosage rules must be followed when giving drugs to elderly patients.

It should, therefore, be clear to anyone with any knowledge of physiology that the only possible argument for trying out drugs on animals is in the hope that the tests will show signs of toxicity. However, even this hope is dashed because there is a huge amount of evidence available to show that animals frequently react quite differently to human beings when given drugs. A cat can’t be expected to react the same way as a dog or a sheep or a cow or a mouse or a guinea pig or a rat or a human being when given a drug. Of course, the simple law of averages means that occasionally there will be results which seem of value – but how is anyone supposed to know which results to take notice of and which to ignore?

Most doctors, even many who support vivisection, will confirm that animal experiments can be misleading. After The European Medical Journal published a survey showing that 88% of doctors agreed that animal experiments can be misleading because of anatomical and physiological differences between animals and humans the editor of the British Medical Journal wrote to say that he felt that most doctors would agree with the phrase that “laboratory experiments performed on animals can be misleading because of anatomical and physiological differences between animals and humans.” The Dean of Medicine at the University of Southampton expressed his surprise that the survey did not find that 100% of the doctors who took part in the survey believed that animal experiments could be misleading. The problem, of course, is that no doctor can tell you which animal experiments are going to be most misleading.

If you test a drug on eight species of animal and the drug turns out to cause cancer in two of those animals, to cause liver problems in another two, to cause blindness in two more and to be quite safe in a final pair should you accept the results from the two that develop cancer, the two who develop liver problems, the two who become blind or the two who remain well?

In practice, of course, no one knows which results to accept and which to ignore and so all the results are ignored (as shown by the number of drugs currently freely available for doctors to prescribe which are known to cause serious problems in animals). The absurdity of the whole business of giving drugs to animals, and expecting to obtain useful results, is taken even further away from logic and practicality by the knowledge that animals in cages behave quite differently to animals in the wild and the understanding that since diet, exercise patterns and genetics all have significant effects on the way human beings respond to disease and drug therapy it is likely that these, or other influences, may also affect animals when they are given drugs.

If we don’t know which (if any) animal experiments are relevant then there is no point in doing any of them.

The essay above is taken from the book `Betrayal of Trust’ by Vernon Coleman first published in 1994.

About the Author

Vernon Coleman MB ChB DSc practised medicine for ten years. He has been a full-time professional author for over 30 years. He is a novelist and campaigning writer and has written many non-fiction books.  He has written over 100 books which have been translated into 22 languages. On his website, www.vernoncoleman.com,  there are hundreds of articles which are free to read.

Share this page to Telegram

Categories: Breaking News, World News

Tagged as:

5 1 vote
Article Rating
Subscribe
Notify of
guest
10 Comments
Inline Feedbacks
View all comments
christine.257
christine.257
30 days ago

Before the vaccines were released into Human arms, they were tested on a herd of Texan Cows, apparently. All of the cows died within a few days except one cow which lasted 9 days then it died, after which the vaccines went into the arms of volunteers with the following results over a 6 month period:CDC Expected Huge Increase in VAERS Reporting of vaccines injuries and deaths.
The contract states that they were expecting up to 1,000 VAERS reports to be filed per day, with up to 40% of the reports being serious in nature:
According to the contract, VAERS had been receiving an annual average of 53,000 reports in recent years, so in contracting for up to 1,000 reports per day, the CDC was already anticipating that the COVID vaccines might generate nearly seven times as many reports as all other vaccines combined (a 600% increase), with a rate of serious adverse events that could be up to 8 times higher.
The initial total amount specified (with options) under the contract with Eagle Health Analytics was $5,925,388.58 or $7,077,054.90 “with all options” (which presumably includes the extension of the VAERS work through July). This amount also includes the CISA project assistance. However, it does not include the increased hours in the Oct. 29 revision, nor the increase for the V-SAFE pregnancy registry work. However, I have not been able to find the contract in any Federal contracts database. Perhaps one of my readers will have better luck.
How Much Did All of This Cost?
The amounts paid out under the contracts with General Dynamics were redacted. But according to this site, the initial amount paid was $9.45 million, with $4.4 million added in late February, and then an additional $16.3 million tacked on in early March. In March of 2022 there was an additional $5.2 million added, though it’s not clear for what since the contract had presumably expired by then. (Best guess is that General Dynamics continued some or all of its work on COVID VAERS reports with Eagle Health brought in for additional support.) Grand total? $35,425,642 of your taxpayer dollars.Military Revealed as Top Funder of Gene Drives; Gates Foundation paid $1.6 million to influence UN on gene drives 2016 December 4, 2017
https://christine257.substack.com/p/there-were-no-covid-19-vaccines-close?utm_source=%2Fsearch%2Fgeneral%2520dynamics&utm_medium=reader2

Anton Cardew
Anton Cardew
30 days ago

So animal experiments are so important so as not to put human life in danger, yet lets go and make a deliberate killing mrna injection, scare them all to death with lies so that they take it and force the reluctant to take it too, ignore all the injuries and deaths and just tell them they have anxiety, this is a fecked up world run by satanists and sociopaths,humans are a failed experiment, enlightment will never come for the necessary majority to change anything, it would have happened by now. When we are given responsibility of dominion over animals, we are judged on how we look after them.

SAbi1
SAbi1
Reply to  Anton Cardew
29 days ago

They are NOT MRNA. They are simply poison – graphene oxide – the base of nanotech, irradiating people from the inside, fortifying the effect of “normal” radiation coming from phones, wifi, smart stuff.

Please carry on (77?) pushing the mRNA lie, there is nothing biological in the poison shots called vax, they are purely technical. Nitrogen and phosphorous were missing, they are the base of life, RNA and DNA.

brinsleyjenkins
brinsleyjenkins
29 days ago

Difficult to comment with nearly zero knowledge apart from knowing a few colleagues who carried out supervised experiments in aviation medicine 70 years ago. Mainly on rats and rabbits before subjecting humans to stress in high gravity experiments, possible outcome was at least predictable. I knew of no human fatalities and these were very early days of man in space research. A rat I recall had its head removed unaware or stressed in the slightest never having felt threat from the lab assistant. The rat died a happy and well cared for animal. I heard of dogs in smoking experiments but know nothing at all of them or any reason for them. It was probably anti smoking pressure? WE know were this led us too and net zero is unappealing to me.

I saw the emergency aircraft chute experiments which had never been thought of until a team of dog handlers had died in a fire and crash. This is standard gear on all passenger aircraft these days so perhaps some good was developed after all. Emotive images may not always give the real story by activists. Maintaining trust in the system is our safeguard, and infringement by charlatans needs attention. I had doubts on the Common Cold Research Unit, never took the kind offer of a paid holiday and refused all jabs in the Services.

Life used to be governed by the law Caveat emptor. this is “Let the buyer beware”. It has become a proverb in English. Generally, caveat emptor is the contract law principle that controls the sale of real property after the date of closing, but may also apply to sales of other goods. The phrase caveat emptor and its use as a disclaimer of warranties arises from the fact that buyers typically have less information than the seller about the good or service they are purchasing. Wikipedia. Perhaps a return to more personal responsibility is called for in our lives?

SAbi1
SAbi1
29 days ago

But satanist enough. Psychos enjoy others suffering.

SAbi1
SAbi1
Reply to  SAbi1
29 days ago

Wow, if you write satanist with small letter, the auto correct will correct it to start it with capital letter. F.off.

karakorum
karakorum
28 days ago

https://премиявызов.рф/images/header-logo_eng.svg

NATIONAL FUTURE TECHNOLOGY AWARD

AREAS OF FUTURE TECHNOLOGY:

https://премиявызов.рф/images/tags-en.svg

LAUREATES OF THE VYZOV PRIZE FOR FUTURE TECHNOLOGIES 2023

comment image

comment image

the Director of the Institute of Translational Biomedicine of St. Petersburg State University

the Institute of Translational Biomedicine of St Petersburg University

which was headed by Raul Radikovich Gainetdinov on April 1, 2015.

The Institute includes:

Laboratory of Neurobiology and Molecular Pharmacology
The head of the laboratory is Gainetdinov Raul Radikovich
..
An important area of our laboratory’s work is devoted to the creation of an original collection of genetically modified lines of laboratory animals for use as the most adequate experimental models of human diseases in animals..
Detailed studies are carried out on these mutant animals using molecular, biochemical, physiological and other approaches that make it possible to identify the mechanisms involved in the pathogenesis of these diseases and thereby identify new targets for the development of innovative pharmacological agents.
..
At the moment, 8 breeds of mice and 4 breeds of rats have been identified and maintained in the laboratory of R.R. Gainetdinov: conventional C57Bl6 mice, CBA mice, Wistar rats and transgenic models: DAT-KO rats, TPH2-KO rats, TAAR9-KO rats, DAT-KO mouse, TAAR1-KO mouse, TAAR2-KO mouse, TAAR5-KO mouse, TAAR6-KO mouse, TAAR8-KO mouse.

the Institute of Translational Biomedicine of St Petersburg University includes also:

Center for Transgenesis and Genome Editing
..
research is carried out on various CRISP/Cas systems used in genome editing..The center implements the entire cycle of work with CRISP/Cas technology
..
Development of new genotyping methods based on CRISPR/Cas systems

Creation of animals that simulate human diseases using CRISPR/Cas systems that make targeted changes to the genome

Improvement of vitrification techniques for cryopreservation of embryos at an early stage of development and rederivation for the development of a line from frozen embryos

comment image

comment image

Laboratory of Neuroprostheses
..
Development and Production of Biocompatible Electrically Conductive Composites for Medical Purposes Based on Carbon Nanomaterials
The project is dedicated to the development of electrically conductive and biocompatible composites designed to create electrodes for neuronal implants.

comment image

Development and Production of Nanostructured Silicone Surfaces to Create a Biocompatible Matrix of Neuronal Implants
The project is dedicated to the production of biocompatible nanostructured surfaces from silicone and its composites, designed to create a matrix of neuronal implants. In the course of the project, methods for obtaining nanostructured surfaces by X-ray, ion-beam and electron lithography should be worked out, mechanical and biological properties of the resulting surfaces should be tested, and optimal morphological parameters of nanostructuring should be identified, at which silicone surfaces are distinguished by a high level of biological compatibility with nerve tissues.

comment image

Patents
1. “Neuronal implant” priority for patent dated 15.05.2020, issued on 07.09.2021; 2. “Method for obtaining neuronal implants” priority for patent dated 09.03.2021, issued on 11.10.2021

…..
Greetings to participants, organisers and guests of Vyzov National Award ceremony
Vladimir Putin sent greetings to the participants, organisers and guests of the ceremony for presenting the Vyzov National Award in the field of future technologies.
en .kremlin. ru
December 19, 2023
..
I would like to emphasise that in recent times, in the context of global changes, large-scale renewal of all sectors of the economy, agriculture, the social sphere, infrastructure and public administration, it is extremely important that promising discoveries and developments of Russian scientists, researchers and designers are implemented in practice as soon as possible, boosting our technological sovereignty, ensuring state security, and improving people’s quality of life.

karakorum
karakorum
28 days ago

comment image

NATIONAL FUTURE TECHNOLOGY AWARD VYZOV [CHALLENGE]

LAUREATES OF THE VYZOV PRIZE FOR FUTURE TECHNOLOGIES 2023

comment image

comment image

the Director of the Institute of Translational Biomedicine of St. Petersburg State University

the Institute of Translational Biomedicine of St Petersburg University

which was headed by Raul Radikovich Gainetdinov on April 1, 2015.

The Institute includes:

Laboratory of Neurobiology and Molecular Pharmacology
The head of the laboratory is Gainetdinov Raul Radikovich
..
An important area of our laboratory’s work is devoted to the creation of an original collection of genetically modified lines of laboratory animals for use as the most adequate experimental models of human diseases in animals..
Detailed studies are carried out on these mutant animals using molecular, biochemical, physiological and other approaches that make it possible to identify the mechanisms involved in the pathogenesis of these diseases and thereby identify new targets for the development of innovative pharmacological agents.
..
At the moment, 8 breeds of mice and 4 breeds of rats have been identified and maintained in the laboratory of R.R. Gainetdinov: conventional C57Bl6 mice, CBA mice, Wistar rats and transgenic models: DAT-KO rats, TPH2-KO rats, TAAR9-KO rats, DAT-KO mouse, TAAR1-KO mouse, TAAR2-KO mouse, TAAR5-KO mouse, TAAR6-KO mouse, TAAR8-KO mouse.

the Institute of Translational Biomedicine of St Petersburg University includes also:

Center for Transgenesis and Genome Editing
..
research is carried out on various CRISP/Cas systems used in genome editing..The center implements the entire cycle of work with CRISP/Cas technology
..
Development of new genotyping methods based on CRISPR/Cas systems

Creation of animals that simulate human diseases using CRISPR/Cas systems that make targeted changes to the genome

Improvement of vitrification techniques for cryopreservation of embryos at an early stage of development and rederivation for the development of a line from frozen embryos

comment image

comment image

Laboratory of Neuroprostheses
..
Development and Production of Biocompatible Electrically Conductive Composites for Medical Purposes Based on Carbon Nanomaterials
The project is dedicated to the development of electrically conductive and biocompatible composites designed to create electrodes for neuronal implants.

comment image

Development and Production of Nanostructured Silicone Surfaces to Create a Biocompatible Matrix of Neuronal Implants
The project is dedicated to the production of biocompatible nanostructured surfaces from silicone and its composites, designed to create a matrix of neuronal implants. In the course of the project, methods for obtaining nanostructured surfaces by X-ray, ion-beam and electron lithography should be worked out, mechanical and biological properties of the resulting surfaces should be tested, and optimal morphological parameters of nanostructuring should be identified, at which silicone surfaces are distinguished by a high level of biological compatibility with nerve tissues.

comment image

Patents
1. “Neuronal implant” priority for patent dated 15.05.2020, issued on 07.09.2021; 2. “Method for obtaining neuronal implants” priority for patent dated 09.03.2021, issued on 11.10.2021

…..
Greetings to participants, organisers and guests of Vyzov National Award ceremony
Vladimir Putin sent greetings to the participants, organisers and guests of the ceremony for presenting the Vyzov National Award in the field of future technologies.
en .kremlin. ru
December 19, 2023
..
I would like to emphasise that in recent times, in the context of global changes, large-scale renewal of all sectors of the economy, agriculture, the social sphere, infrastructure and public administration, it is extremely important that promising discoveries and developments of Russian scientists, researchers and designers are implemented in practice as soon as possible, boosting our technological sovereignty, ensuring state security, and improving people’s quality of life.